Profile and investment
| Fund type | Open Ended Investment Company |
|---|---|
| Investment style (stocks) | Market Cap: Large Investment Style: Growth |
| Morningstar category | Foreign Large Value |
| Launch date | 26 Sep 1997 |
| Price currency | USD |
| Domicile | United States |
| Symbol | BIDD |
| Manager & start date | Olivia Treharne 26 Sep 1997 Molly Greenen 26 Sep 1997 |
| Pricing frequency | Daily |
|---|---|
| Total net assets | -- |
| Share class size | -- |
| Net expense ratio | 0.61% |
| Front end load | -- |
| Deferred load | -- |
| Maximum Redemption Fee | -- |
| Min. initial investment | -- |
| Min. additional investment | -- |
| Initial IRA | -- |
| Additional IRA | -- |
| Available for sale | United States |
More ▼
Top 5 holdings
| Top 5 holdings as a per cent of portfolio | |||
|---|---|---|---|
| 13.88% | 21.63% | 0.00% | 21.63% |
| Category average | % Net assets | % Short | % Long |
| Company | 1 year change | Portfolio weight | Long allocation |
|---|---|---|---|
| Taiwan Semiconductor Manufacturing Co Ltd 2330:TAI | +72.65% | 6.26% | |
| Novo Nordisk A/S NOVO B:CPH | +3.01% | 4.64% | |
| ASML Holding NV ASML:AEX | +0.93% | 3.65% | |
| Air Liquide AI:PAR | +2.10% | 3.56% | |
| AstraZeneca PLC AZN:LSE | -1.28% | 3.52% | |
| Per cent of portfolio in top 5 holdings: 21.63% |
Asset type
| Non-US stock | 85.84% |
| US stock | 13.38% |
| Cash | 0.70% |
| US bond | 0.00% |
| Non-US bond | 0.00% |
| Other | 0.08% |
Top 5 sectors
| Technology | 20.47% |
| Industrials | 20.16% |
| Financial Services | 15.21% |
| Healthcare | 13.14% |
| Consumer Cyclical | 7.18% |
| Other | 23.05% |
Top 5 regions
| Eurozone | 30.50% |
| United Kingdom | 18.55% |
| Europe - ex Euro | 13.91% |
| United States | 13.38% |
| Developed Asia | 8.05% |
| Other | 14.84% |
Sector and region weightings are calculated using only long position holdings of the portfolio.
